Beautiful Virgin Islands

Monday, Jul 14, 2025

Dexamethasone can help save lives of very ill patients, British trial into low-cost drug finds

Dexamethasone can help save lives of very ill patients, British trial into low-cost drug finds

Researchers gave the anti-inflammatory drug to some 2,000 hospitalised patients. Dexamethasone reduced deaths by one-third for patients on ventilators and one-fifth among patients who were on supplemental oxygen

A low-cost and widely available drug has been found to reduce the death rate by one-third among most severe Covid-19 patients, according to trial data published on Tuesday.

Dexamethasone, a generic anti-inflammatory medication, was hailed as the first life-saving drug by the University of Oxford scientists leading the coronavirus treatment testing project named “RECOVERY”.

Scientists around the world are racing against the clock to find a treatment for Covid-19, the illness caused by the new coronavirus that has sickened over 8 million and killed more than 431,000 globally. There are currently no specific treatments or vaccines for the deadly virus.

The trial gave a low dose – 6 milligrams – of the steroid to 2,104 hospitalised patients for 10 days and results were compared with 4,321 patients who did not use the drug.

Dexamethasone reduced deaths by one-third for patients on ventilators and one-fifth among patients who were on supplemental oxygen, compared to those who only received usual care.

However, the drug showed no benefit to those who did not require respiratory support, which is generally to assist the more critical patients.

The findings were published through a statement on Tuesday. There was no mention of peer review.

The Oxford researchers said they are “now working to publish the full details as soon as possible”, but are calling for the drug to become the “standard of care” in patients requiring oxygen treatment.

“The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients,” said Peter Horby, a professor of emerging infectious diseases and global health at the University of Oxford and one of the chief investigators for the trial.

Martin Landray, a professor of medicine and epidemiology at Oxford and also one of the chief investigators, said that the results showed the drug is the “first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide”.

“It’s going to be very hard for any drug really to replace this, given that for less than £50 [$63] you can treat eight patients and save a life,” Landray said in an online briefing.

Nick Cammack, Covid-19 therapeutics accelerator lead at UK-based research charity Wellcome Trust called for the drug to be used worldwide.

“Dexamethasone must now be rolled out and accessed by thousands of critically ill patients around the world. It is highly affordable, easy to make, can be scaled up quickly and only needs a small dosage. Any and every successful treatment against Covid-19 must be made available to everyone who needs it globally, regardless of their ability to pay,” Cammack said.

“Potentially preventing one death in every eight ventilated patients would be remarkable,” he said. “While this study suggests dexamethasone only benefits severe cases, countless lives will be saved globally.”

An antiviral drug, remdesivir, is also being used in the treatment of patients in some countries with the benefits of shortening treatment time but scientists have different views about its effectiveness.





Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
President Trump Visits Flood-Ravaged Texas, Praises Community Strength and First Responders
From Mystery to Meltdown, Crisis Within the Trump Administration: Epstein Files Ignite A Deepening Rift at the Highest Levels of Government Reveals Chaos, Leaks, and Growing MAGA Backlash
Trump Slams Putin Over War Death Toll, Teases Major Russia Announcement
Reparations argument crushed
Rainmaker CEO Says Cloud Seeding Paused Before Deadly Texas Floods
A 92-year-old woman, who felt she doesn't belong in a nursing home, escaped the death-camp by climbing a gate nearly 8 ft tall
French Journalist Acquitted in Controversial Case Involving Brigitte Macron
Elon Musk’s xAI Targets $200 Billion Valuation in New Fundraising Round
Kraft Heinz Considers Splitting Off Grocery Division Amid Strategic Review
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
EU Proposes New Tax on Large Companies to Boost Budget
Trump Imposes 35% Tariffs on Canadian Imports Amid Trade Tensions
Junior Doctors in the UK Prepare for Five-Day Strike Over Pay Disputes
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
Bitcoin Reaches New Milestone of $116,000
Biden’s Doctor Pleads the Fifth to Avoid Self-Incrimination on President’s Medical Fitness
Grok Chatbot Faces International Backlash for Antisemitic Content
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
US Imposes New Tariffs on Brazilian Exports Amid Political Tensions
Azerbaijan and Armenia are on the brink of a historic peace deal.
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Weinstein Victim’s Lawyer Says MeToo Movement Still Strong
U.S. Enacts Sweeping Tax and Spending Legislation Amid Trade Policy Shifts
×